Monti, D. A., Mitchell, E., Bazzan, A. J., Littman, S., Zabrecky, G., Yeo, C. J., . . . Levine, M. (2012). Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Monti, Daniel A., et al. Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer. Public Library of Science (PLoS), 2012.
Cita MLA (8a ed.)Monti, Daniel A., et al. Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer. Public Library of Science (PLoS), 2012.
Precaución: Estas citas no son 100% exactas.